TAL1 Antikörper
Kurzübersicht für TAL1 Antikörper (ABIN7075819)
Target
Alle TAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Ratte
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant protein corresponding to Mouse Tal1
-
-
-
-
Applikationshinweise
- IHC/IF (R) 1:800-1:1500/1:400-1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
-
Andere Bezeichnung
- Tal1
-
Hintergrund
- Activation of TAL1 characterizes up to 60 % of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase alpha, a serine/ threonine protein kinase known to modulate the activity of other bHLH transcription factors.
-
Gen-ID
- 21349
-
NCBI Accession
- NP_001274317
-
UniProt
- P22091
-
Pathways
- Stem Cell Maintenance
Target
-